The enhanced antitumour response of pimozide combined with the IDO inhibitor L-MT in melanoma

Melanoma is one of the most fatal and therapy-resistant types of cancer; therefore, identifying novel therapeutic candidates to improve patient survival is an ongoing effort. Previous studies have revealed that pimozide is not sufficient to treat melanoma; therefore, enhancing the treatment is neces...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Oncol
Autores principales: Jia, Huijie, Ren, Wenjing, Feng, Yuchen, Wei, Tian, Guo, Mengmeng, Guo, Jing, Zhao, Jingjing, Song, Xiangfeng, Wang, Mingyong, Zhao, Tiesuo, Wang, Hui, Feng, Zhiwei, Tian, Zhongwei
Formato: Artigo
Lenguaje:Inglês
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6065445/
https://ncbi.nlm.nih.gov/pubmed/30015838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2018.4473
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares